-S E Pinder Researcher Activity Profile

Research Author Detailed Information 

S E Pinder Publication Rate By Year

S E Pinder has published 1 paper(s) in 1998, 1 paper(s) in 2006, 15 paper(s) in 2007, 8 paper(s) in 2008, for a total of 25 research publications in total.

S E Se Pinder Author Information

LAST NAME: pinder

FIRST NAME: S E

INITIALS: se

AFFILIATION:

Papers

S E Pinder's Publication Record

1. Adenomyoepithelioma of the breast; a case report and literature review. Year Published: 2007
Cambridge Breast Unit, Addenbrookes Hospital, Cambridge University Hospital NHS Foundation Trust, UK.
2. Reading the prognosis of the individual with breast cancer. Year Published: 2007
The Breast Institute, Nottingham City Hospital, Nottingham NG5 1PB, UK. wendy.bartlam@nuh.nhs.uk
3. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Year Published: 2007
The Breast Institute, Nottingham City Hospital, Nottingham NG5 1PB, UK. wendy.bartlam@nuh.nhs.uk
4. P-glycoprotein expression is associated with sestamibi washout in primary hyperparathyroidism. Year Published: 2007
Department of Endocrine Surgery, Addenbrooke's Hospital, Cambridge, UK.
5. Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Year Published: 2007
Department of Academic Oncology, King's College London and Guy's & St Thomas' NHS Foundation Trust, United Kingdom.
6. Non-operative breast pathology: columnar cell lesions. Year Published: 2007
Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK. sep43@cam.ac.uk
7. Non-operative breast pathology: lobular neoplasia. Year Published: 2007
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. Jorge.Reis-Filho@icr.ac.uk
8. Non-operative breast pathology. Year Published: 2007
9. Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up. Year Published: 2007
Radiology, Breast Institute, Nottingham City Hospital, Nottingham, UK.
10. Non-operative breast pathology: columnar cell lesions. Year Published: 2007
Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK. sep43@cam.ac.uk
11. Non-operative breast pathology: lobular neoplasia. Year Published: 2007
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. Jorge.Reis-Filho@icr.ac.uk
12. Non-operative breast pathology. Year Published: 2007
13. P-glycoprotein expression is associated with sestamibi washout in primary hyperparathyroidism. Year Published: 2007
Department of Endocrine Surgery, Addenbrooke's Hospital, Cambridge, UK.
14. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Year Published: 2008
Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. aet21@cam.ac.uk.
15. Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Year Published: 2007
Department of Academic Oncology, King's College London and Guy's & St Thomas' NHS Foundation Trust, United Kingdom.
16. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Year Published: 2008
Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. aet21@cam.ac.uk.
17. Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up. Year Published: 2007
Radiology, Breast Institute, Nottingham City Hospital, Nottingham, UK. andrew.evans@nuh.nhs.uk
18. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Year Published: 2008
Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. aet21@cam.ac.uk
19. Fibroadenomatoid hyperplasia: a cause of suspicious microcalcification on mammographic screening. Year Published: 1998
Department of Radiology, Nottingham City Hospital, United Kingdom.
20. Is mammographic spiculation an independent, good prognostic factor in screening-detected invasive breast cancer? Year Published: 2006
Breast Institute, Nottingham International Breast Education Center and Nottingham City Hospital, Hucknall Rd., Nottingham NG5 1PB, United Kingdom.
21. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Year Published: 2008
Breast Cancer Functional Genomics, Cancer Research UK Cambridge Research Institute and Department of Oncology University of Cambridge, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. sc10021@cam.ac.uk.
22. Diagnostic, predictive and prognostic breast pathology. Editorial. Year Published: 2008
Professor of Breast Pathology, Kings College London, Department of Academic Oncology, 3rd Floor Thomas Guy House, Guy's Hospital, St Thomas Street, London SE1 9RT, UK.
23. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Year Published: 2008
Breast Cancer Functional Genomics, Cancer Research UK Cambridge Research Institute and Department of Oncology University of Cambridge, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. sc10021@cam.ac.uk
24. Diagnostic, predictive and prognostic breast pathology. Editorial. Year Published: 2008
Professor of Breast Pathology, Kings College London, Department of Academic Oncology, 3rd Floor Thomas Guy House, Guy's Hospital, St Thomas Street, London SE1 9RT, UK.
25. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Year Published: 2008
Addenbrookes NHS Foundation Trust, Cambridge, UK.